CSRxP Statement On HHS DTC Advertising Announcement
CSRxP issued the following statement in response to the U.S. Department of… Read More
© 2026 CSRXP- All Rights Reserved
CSRxP Statement On PhRMA’s DTC Advertising Announcement
The Campaign for Sustainable Rx Pricing (CSRxP) issued the following statement… Read More
ICYMI: CSRxP Calls On FDA To Break Down Barriers To Affordable Drugs
Through the advancement of modern medicine, biologic drugs are providing new… Read More
Congress Rejects Big Pharma Bailout
Defeat For Price-Gouging Drug Manufacturers; Victory For Taxpayers &… Read More
Second Opinion: The Truth About The Big Pharma Bailout
In their latest attempt to make billions of dollars on the backs of patients,… Read More
CSRxP Urges Congress to Stop Big Pharma’s $4 Billion Bailout
Washington, D.C. – Today the Campaign for Sustainable Rx Pricing… Read More
CSRxP Statement on Potential Big Pharma Bailout
“Only Big Pharma would use bipartisan opioid legislation as another… Read More
Stop Big Pharma’s $4 Billion Bailout
As the country is hoping for lower drug prices, more affordable care… Read More
CSRxP Statement On Exclusion Of Big Pharma Accountability Amendment In Appropriations Bill
House Misses Bipartisan Opportunity To Hold Big Pharma Accountable… Read More
SECOND OPINION: Big Pharma Continues Pointing Fingers for Excessive Drug Prices
Apparently, when it comes to out-of-control drug prices, everyone’s to blame… Read More
Second Opinion: The Real Source of Rising Drug Prices
Big Pharma is always eager to play the blame game – attempting to divert… Read More
CSRxP Urges House Members To Maintain Transparency Provision In Senate-Passed Appropriations Bill
CSRxP-Supported Policy Enables HHS To Require Drug Price Disclosure In… Read More